Victor L Serebruany Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

7/2017	Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting.
1/2017	Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
1/2016	Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar.
1/2015	The Dual Antiplatelet Therapy Trial after the FDA Update: Noncardiovascular Deaths, Cancer and Optimal Treatment Duration.
1/2014	Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
1/2013	Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
12/2012	Viewpoint: reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel.
7/2010	Stability validation of paraformaldehyde-fixed samples for the assessment of the platelet PECAM-1, P-selectin, and PAR-1 thrombin receptor by flow cytometry.
1/2010	Mortality benefit in PLATO cannot be explained by antiplatelet properties of ticagrelor.
6/2008	Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor L Serebruany Research Topics

Disease

41	Hemorrhage 07/2017 - 04/2003
36	Myocardial Infarction 11/2019 - 08/2002
25	Stroke (Strokes) 07/2021 - 03/2003
23	Acute Coronary Syndrome 01/2017 - 12/2002
18	Heart Failure 11/2019 - 01/2002
15	Ischemic Stroke 11/2019 - 10/2003
14	Thrombosis (Thrombus) 07/2017 - 02/2003
14	Neoplasms (Cancer) 03/2017 - 05/2009
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 02/2003
8	Peripheral Arterial Disease 03/2017 - 01/2009
8	ST Elevation Myocardial Infarction 10/2015 - 11/2006
8	Vascular Diseases (Vascular Disease) 07/2010 - 01/2004
5	Dyspnea (Shortness of Breath) 01/2017 - 11/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 09/2005
4	Non-ST Elevated Myocardial Infarction 01/2017 - 05/2013
4	Unstable Angina 05/2013 - 12/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 05/2006
3	Hypertension (High Blood Pressure) 01/2016 - 01/2006
3	Coronary Disease (Coronary Heart Disease) 01/2016 - 01/2015
3	Headache (Headaches) 11/2014 - 05/2006
3	Type 2 Diabetes Mellitus (MODY) 11/2014 - 01/2008
3	Atrial Fibrillation 05/2011 - 01/2010
2	Diplopia (Double Vision) 03/2017 - 01/2016
2	Chest Pain (Chest Pains) 01/2017 - 08/2002
2	Sepsis (Septicemia) 12/2015 - 11/2014
2	Infections 03/2015 - 11/2014
2	Transfusion-Related Acute Lung Injury 01/2014 - 12/2012
2	Constipation 01/2013 - 11/2010
2	Inflammation (Inflammations) 01/2013 - 01/2012
2	Nausea 01/2013 - 02/2008
2	Vomiting 01/2013 - 02/2008
2	Atherosclerosis 01/2013 - 07/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2012 - 08/2003
2	Sudden Death 01/2011 - 01/2010
2	Transient Ischemic Attack 02/2008 - 01/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2003 - 08/2002
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2017
1	Confusion (Bewilderment) 01/2017
1	Pulmonary Embolism 01/2017
1	Bradycardia 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Syncope (Fainting) 01/2016

Drug/Important Bio-Agent (IBA)

49	Clopidogrel (Plavix)FDA Link 03/2017 - 02/2003
47	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2017 - 06/2002
24	Prasugrel Hydrochloride FDA Link 11/2015 - 01/2008
21	TicagrelorIBA 07/2021 - 01/2010
15	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2017 - 01/2004
15	Pharmaceutical PreparationsIBA 02/2016 - 12/2002
13	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2002
11	vorapaxarIBA 03/2017 - 01/2015
8	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2017 - 01/2013
7	Thrombin Receptors (Thrombin Receptor)IBA 07/2016 - 05/2006
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013 - 08/2003
7	Dipyridamole (Persantine)FDA LinkGeneric 02/2008 - 04/2003
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2015 - 04/2003
4	Warfarin (Coumadin)FDA LinkGeneric 11/2019 - 03/2003
4	Thrombin FDA Link 03/2017 - 09/2015
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2006 - 08/2003
3	AnticoagulantsIBA 11/2019 - 01/2006
3	C-Reactive ProteinIBA 01/2016 - 03/2004
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2016 - 01/2002
3	PyrimidinesIBA 09/2015 - 01/2010
3	ThienopyridinesIBA 09/2015 - 12/2012
3	Valsartan (Vals)FDA Link 11/2014 - 05/2004
3	cangrelorIBA 01/2014 - 11/2013
3	Purinergic P2Y Receptor AntagonistsIBA 01/2013 - 03/2003
3	Rosuvastatin Calcium (Crestor)FDA Link 01/2013 - 05/2006
3	Adenosine (Adenocard)FDA LinkGeneric 12/2012 - 01/2010
3	Antidepressive Agents (Antidepressants)IBA 01/2009 - 08/2003
3	Dipyridamole Drug Combination Aspirin FDA LinkGeneric 05/2006 - 04/2003
2	apixabanIBA 11/2019 - 09/2015
2	Troponin IIBA 01/2017 - 11/2006
2	Troponin T (Troponin T1)IBA 01/2016 - 03/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2016 - 01/2015
2	PAR-1 ReceptorIBA 01/2016 - 01/2007
2	Heparin (Liquaemin)FDA LinkGeneric 09/2015 - 01/2006
2	von Willebrand FactorIBA 01/2015 - 06/2011
2	Adenosine Diphosphate (ADP)IBA 01/2014 - 06/2002
2	Eptifibatide (Integrilin)FDA Link 01/2014 - 12/2002
2	elinogrelIBA 01/2014 - 12/2012
2	Atorvastatin (Lipitor)FDA Link 01/2013 - 05/2006
2	Simvastatin (Zocor)FDA LinkGeneric 01/2013 - 05/2006
2	Platelet Endothelial Cell Adhesion Molecule-1IBA 07/2010 - 09/2003
2	P-SelectinIBA 07/2010 - 09/2003
2	Sertraline (Zoloft)FDA LinkGeneric 06/2005 - 08/2003
1	Vitamin K FDA Link 11/2019
1	Dabigatran FDA Link 11/2019
1	RivaroxabanIBA 11/2019
1	IvabradineIBA 01/2019
1	Radioisotopes (Radionuclides)IBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 01/2016
1	CreatinineIBA 01/2016
1	phorbol 12-pyrenebutyrate 13-(3,3,3-trifloro-2-diazopropioate)IBA 12/2015

Therapy/Procedure

38	Therapeutics 01/2017 - 06/2002
11	Stents 01/2016 - 10/2002
9	Percutaneous Coronary Intervention 01/2017 - 08/2010
7	Secondary Prevention 03/2014 - 05/2006
2	Duration of Therapy 12/2015 - 01/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016